Xenon Pharmaceuticals Cash from Financing (TTM) Analysis

Xenon Pharmaceuticals Inc (XENE)

41.35 +0.05 (+0.12%) USD | NASDAQ | Apr 15, 16:00

41.29 -0.06 (-0.15%) After-Hours: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2014. Upgrade now.

Date	Value
December 31, 2023	353.52M
September 30, 2023	29.51M
June 30, 2023	0.705M
March 31, 2023	270.60M
December 31, 2022	278.47M
September 30, 2022	602.42M
June 30, 2022	606.48M
March 31, 2022	336.70M
December 31, 2021	447.54M
September 30, 2021	123.64M
June 30, 2021	118.88M
March 31, 2021	102.05M
December 31, 2020	85.80M
September 30, 2020	113.18M
June 30, 2020	113.20M
March 31, 2020	129.93M
December 31, 2019	27.52M
September 30, 2019	0.121M
June 30, 2019	77.53M

Date	Value
March 31, 2019	111.53M
December 31, 2018	111.59M
September 30, 2018	118.45M
June 30, 2018	41.02M
March 31, 2018	7.015M
December 31, 2017	7.07M
September 30, 2017	0.225M
June 30, 2017	24.06M
March 31, 2017	24.09M
December 31, 2016	23.96M
September 30, 2016	23.95M
June 30, 2016	0.147M
March 31, 2016	0.195M
December 31, 2015	0.278M
September 30, 2015	42.66M
June 30, 2015	42.06M
March 31, 2015	41.64M
December 31, 2014	41.12M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

0.121M

Minimum

Sep 2019

606.48M

Maximum

Jun 2022

200.94M

Average

118.88M

Median

Jun 2021

Cash from Financing (TTM) Benchmarks